DBS-20 · Baseline Series
19 allergen and mix positions. One negative control. Two individually sealed, ready-to-use panels.
View panel composition ↓
For professional use only · Rx onlyKnow every position
Two columns of five positions per panel. Explore the full composition below, or search for a specific allergen.
| No. | Allergen / mix | Concentration |
|---|---|---|
| 01 | Nickel sulfate hexahydrate | 2.5% pet. |
| 02 | Potassium dichromate | 0.5% pet. |
| 03 | Cobaltous chloride hexahydrate | 1.0% pet. |
| 04 | Fragrance mix I (incl. 8 allergens) | 8.0% pet. |
| 05 | Fragrance mix II (incl. 6 allergens) | 14.0% pet. |
| 06 | Peru balsam | 25.0% pet. |
| 07 | Formaldehyde | 2.0% aq. |
| 08 | Paraben mix (incl. 4 allergens) | 16.0% pet. |
| 09 | Methylisothiazolinone + Methylchloroisothiazolinone | 0.215% aq. |
| 10 | Quaternium-15 | 2.0% pet. |
| No. | Allergen / mix | Concentration |
|---|---|---|
| 11 | Diazolidinyl urea | 2.0% pet. |
| 12 | Thiuram mix (incl. 4 allergens) | 1.0% pet. |
| 13 | Mercapto mix (incl. 4 allergens) | 3.5% pet. |
| 14 | p-Phenylenediamine | 1.0% pet. |
| 15 | Lanolin alcohols | 30.0% pet. |
| 16 | Budesonide | 0.01% pet. |
| 17 | Rosin | 20.0% pet. |
| 18 | Oxybenzone | 10.0% pet. |
| 19 | 2-Hydroxyethyl methacrylate | 2.0% pet. |
| 20 | Negative control (uncoated polyester patch spot) | — |
pet. = petrolatum (w/w). aq. = aqueous/water (w/v). Composition shown in the ASCIA 2026 product flyer. Always refer to the current, market-specific IFU supplied with your product.
A baseline series is not exhaustive. Additional allergens, patient products or exposure-specific testing may be appropriate based on clinical history and judgement.
Skin-activated gel release
Pre-coated allergens in a dehydrated hydrophilic gel matrix.
After application, moisture at the skin interface rehydrates the gel and supports allergen release. The pre-coated format means no mixing or manual loading before application.
Use only in accordance with the current, market-specific Instructions for Use.
Included in your workflow
The panel-specific paper Reading Cards align with retained skin reference marks, helping you identify each test site after removal.
Preserve the marksMaintain the reference points made at application.
Realign the cardMatch the corresponding Panel A or Panel B card to the marks.
Identify and recordDocument the mapped site, clinical grade and relevance.
Illustration shown. Reading Cards support identification, not diagnosis. Follow the current IFU for reading times and interpretation.
Professional information
Interpret findings alongside the patient’s history and exposure. A baseline series is not exhaustive; additional testing may be appropriate.
Request the current IFUThis is a summary, not the complete safety information. Refer to the current IFU for complete indications, contraindications, warnings, precautions and reading schedules.
Professional questions
Product information for clinicians and practice teams. The current, market-specific IFU takes precedence over this website summary.
Ask our teamDermagy Baseline Series (DBS-20) is a ready-to-use, pre-coated allergen patch-test series for qualified healthcare professionals. It comprises two panels and supports clinician-led evaluation of suspected allergic contact dermatitis. It is not for self-testing or home use.
Read the safety summaryThere are 20 positions across two panels: 19 allergen and mix positions plus one negative control. Each panel has ten positions, arranged in two columns of five. An allergen mix can contain multiple constituents; the position count is not a count of individual allergenic substances.
View names and concentrationsNo mixing or manual allergen loading is needed before application. The allergens are pre-coated in a dehydrated hydrophilic gel matrix. Moisture at the skin interface rehydrates the gel and supports allergen release. Preparation and application must follow the current IFU.
Explore the gel technologyThe paper Reading Cards have die-cut windows matching the panel positions. After panel removal, the corresponding card aligns with retained reference marks to help identify and document test sites. It does not diagnose a reaction or replace clinician-led grading and interpretation.
Explore the Reading Card workflowUse the sample request form to provide your professional and practice details. MAG Pharma reviews the request and follows up by email. Submitting a request does not guarantee eligibility or supply; local requirements and availability must be confirmed.
Request a Baseline sampleSelect Baseline Series and submit the requested quantity, professional details and delivery information through the order request form. The team follows up by email about pricing, availability and next steps. This is a request for review, not an online payment or automatic order acceptance.
Submit an order requestNot yet. The Medicament & Preservative, Fragrance & Personal Care, and Materials & Occupational Extension Packages remain in development. They are not available for ordering or sampling. Baseline Series is the current product for sample and order requests.
Explore the development conceptsExplore the wider Dermagy family
Our Extension Packages build on an exposure-led concept. All three remain in development and are not yet available for orders or samples.
The Extension programmeA development programme focused on contact allergens associated with topical therapies and preservative ingredients.
View concept & planned allergensA development programme focused on ingredients encountered in personal-care and cosmetic products.
View concept & planned allergensA development programme focused on contact exposures associated with materials and the workplace.
View concept & planned allergens
